CMS proposes changes to increase Medicaid drug price transparency
The Centers for Medicare & Medicaid Services this week proposed changes to the Medicaid Drug Rebate Program intended to improve manufacturer data integrity and help states verify drug prices. CMS will accept comments on the proposed rule through July 25.
Related News Articles
Headline
The Department of Health and Human Services July 2 announced it will provide Medicaid and Children's Health Insurance Program coverage to incarcerated people…
Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
A report released May 29 by the Government Accountability Office found a lack of state oversight on Medicaid managed care plans’ use of prior authorization for…
Headline
The Centers for Medicare & Medicaid Services is seeking public comments until July 22 on the information requirements associated with attestation…
Headline
The Centers for Medicare & Medicaid Services recently announced the approval of Delaware and Tennessee as the first states to provide diapers to children…
Headline
The Centers for Medicare & Medicaid Services May 9 announced an extension of unwinding flexibilities to support state efforts to protect the continuity of…